Search research articles
Contact Us
Filters
Showing results (31-40 of 53) with videos related to
Page
of 6
Sort By:
British Journal of Haematology
|
March 1, 1990
Elevated white blood cell synthesis of leukotriene C4 in chronic myelogenous leukaemia but not in polycythaemia vera
L Stenke, J Samuelsson, J Palmblad, et al.
Advances in Prostaglandin, Thromboxane, and Leukotriene Research
|
January 1, 1991
Lipoxygenase products in myeloproliferative disorders: increased leukotriene C4 and decreased lipoxin formation in chronic myeloid leukemia
L Stenke, B Näsman-Glaser, C Edenius, et al.
Journal of Leukocyte Biology
|
August 26, 1998
Expression of mRNA encoding neurotrophins and neurotrophin receptors in human granulocytes and bone marrow cells--enhanced neurotrophin-4 expression induced by LTB4
M A Laurenzi, T Beccari, L Stenke, et al.
Blut
|
February 1, 1987
Dilution and hemolysis causing anaemia after artificial heart implantation
L Stenke, R Hast, E Osby, et al.
Radiation Protection Dosimetry
|
November 13, 2018
COORDINATION OF MANAGEMENT OF THE ACUTE RADIATION SYNDROME
L Stenke, K Lindberg, M Lagergren Lindberg, et al.
Advances in Experimental Medicine and Biology
|
January 1, 1991
Metabolism of granulocyte-derived leukotriene A4 in human platelets and respiratory tissue: transcellular formation of lipoxins and leukotrienes
C Edenius, L Stenke, S Tornhamre, et al.
Blood
|
February 9, 2000
Aberrant expression of active leukotriene C(4) synthase in CD16(+) neutrophils from patients with chronic myeloid leukemia
M Sjölinder, L Stenke, B Näsman-Glaser, et al.
Journal of Lipid Mediators
|
March 1, 1993
Formation and effects of leukotrienes and lipoxins in human bone marrow
J A Lindgren, L Stenke, M Mansour, et al.
Radiation Protection Dosimetry
|
August 31, 2016
Lessons Learnt from the Fukushima Accident-A Swedish Medical Preparedness Perspective
L Stenke, J von Schreeb, M Simonsson, et al.
Bone Marrow Transplantation
|
January 1, 1994
Intensive treatment in order to minimize the Ph-positive clone in chronic myelogenic leukemia (CML). Swedish CML-group
B Simonsson, G Oberg, A Killander, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 53) with videos related to
Sort By:
Page
of 6
British Journal of Haematology
|
March 1, 1990
Elevated white blood cell synthesis of leukotriene C4 in chronic myelogenous leukaemia but not in polycythaemia vera
L Stenke, J Samuelsson, J Palmblad, et al.
Advances in Prostaglandin, Thromboxane, and Leukotriene Research
|
January 1, 1991
Lipoxygenase products in myeloproliferative disorders: increased leukotriene C4 and decreased lipoxin formation in chronic myeloid leukemia
L Stenke, B Näsman-Glaser, C Edenius, et al.
Journal of Leukocyte Biology
|
August 26, 1998
Expression of mRNA encoding neurotrophins and neurotrophin receptors in human granulocytes and bone marrow cells--enhanced neurotrophin-4 expression induced by LTB4
M A Laurenzi, T Beccari, L Stenke, et al.
Blut
|
February 1, 1987
Dilution and hemolysis causing anaemia after artificial heart implantation
L Stenke, R Hast, E Osby, et al.
Radiation Protection Dosimetry
|
November 13, 2018
COORDINATION OF MANAGEMENT OF THE ACUTE RADIATION SYNDROME
L Stenke, K Lindberg, M Lagergren Lindberg, et al.
Advances in Experimental Medicine and Biology
|
January 1, 1991
Metabolism of granulocyte-derived leukotriene A4 in human platelets and respiratory tissue: transcellular formation of lipoxins and leukotrienes
C Edenius, L Stenke, S Tornhamre, et al.
Blood
|
February 9, 2000
Aberrant expression of active leukotriene C(4) synthase in CD16(+) neutrophils from patients with chronic myeloid leukemia
M Sjölinder, L Stenke, B Näsman-Glaser, et al.
Journal of Lipid Mediators
|
March 1, 1993
Formation and effects of leukotrienes and lipoxins in human bone marrow
J A Lindgren, L Stenke, M Mansour, et al.
Radiation Protection Dosimetry
|
August 31, 2016
Lessons Learnt from the Fukushima Accident-A Swedish Medical Preparedness Perspective
L Stenke, J von Schreeb, M Simonsson, et al.
Bone Marrow Transplantation
|
January 1, 1994
Intensive treatment in order to minimize the Ph-positive clone in chronic myelogenic leukemia (CML). Swedish CML-group
B Simonsson, G Oberg, A Killander, et al.
Page
of 6